Literature DB >> 20582593

My living history to pediatric neurosurgery.

Tai-Tong Wong1.   

Abstract

Mesh：

Year:  2010        PMID： 20582593     DOI： 10.1007/s00381-010-1193-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


× No keyword cloud information.
  6 in total

1.  A method of enlarging the opening of the third ventricular floor for flexible endoscopic third ventriculostomy.

Authors:  T T Wong; L S Lee
Journal:  Childs Nerv Syst       Date:  1996-07       Impact factor: 1.475

2.  Percutaneous third ventriculostomy in the management of noncommunicating hydrocephalus.

Authors:  H J Hoffman; D Harwood-Nash; D L Gilday
Journal:  Neurosurgery       Date:  1980-10       Impact factor: 4.654

3.  Seizure outcome after corpus callosotomy: the Taiwan experience.

Authors:  S Y Kwan; T T Wong; K P Chang; C S Chi; T F Yang; Y C Lee; W Y Guo; M S Su
Journal:  Childs Nerv Syst       Date:  2000-02       Impact factor: 1.475

Review 4.  [History of epilepsy surgery at The Hospital for Sick Children in Toronto, Canada].

Authors:  Hiroshi Otsubo
Journal:  No Shinkei Geka       Date:  2006-12

5.  Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004).

Authors:  Tai-Tong Wong; Donald M Ho; Kai-Ping Chang; Sang-Hue Yen; Wan-You Guo; Feng-Chi Chang; Muh-Lii Liang; Hung-Chi Pan; Wen-Yuh Chung
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

6.  The history of neurosurgery at the Hospital for Sick Children in Toronto.

Authors:  Andrew Jea; Merdas Al-Otibi; James T Rutka; James M Drake; Peter B Dirks; Abhaya V Kulkarni; Michael D Taylor; Robin P Humphreys
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654
  6 in total
  1 in total

1.  Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan.

Authors:  Yuan-Hung Wu; Feng-Chi Chang; Muh-Lii Liang; Hsin-Hung Chen; Tai-Tong Wong; Sang-Hue Yen; Yi-Wei Chen
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.